Cargando…
T-cells in chronic lymphocytic leukemia: Guardians or drivers of disease?
Chronic lymphocytic leukemia (CLL) is a B-cell malignancy, which is associated with profound alterations and defects in the immune system and a prevalent dependency on the microenvironmental niche. An abnormal T-cell compartment in the blood of CLL patients was already reported 40 years ago. Since t...
Autores principales: | Roessner, Philipp M., Seiffert, Martina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318881/ https://www.ncbi.nlm.nih.gov/pubmed/32457353 http://dx.doi.org/10.1038/s41375-020-0873-2 |
Ejemplares similares
-
Publisher Correction: T cells in chronic lymphocytic leukemia: guardians or drivers of disease?
por: Roessner, Philipp M., et al.
Publicado: (2021) -
IDO1-Targeted Therapy Does Not Control Disease Development in the Eµ-TCL1 Mouse Model of Chronic Lymphocytic Leukemia
por: Öztürk, Selcen, et al.
Publicado: (2021) -
Simultaneous Inhibition of PI3Kgamma and PI3Kdelta Deteriorates T-cell Function With Implications for Chronic Lymphocytic Leukemia
por: Faehling, Sebastian, et al.
Publicado: (2023) -
Combining ibrutinib and checkpoint blockade improves CD8+ T-cell function and control of chronic lymphocytic leukemia in E-TCL1 mice
por: Hanna, Bola S., et al.
Publicado: (2020) -
TIGIT: an immune checkpoint beyond T cells in chronic lymphocytic leukemia
por: Seiffert, Martina
Publicado: (2023)